InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,254.64
(
0.01%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vieuxblue

Send PM Follow Ignore
Followers 0
Posts 50
Boards Moderated 0
Alias Born 11/15/2003

vieuxblue

Re: None

Thursday, 08/11/2005 10:12:55 AM

Thursday, August 11, 2005 10:12:55 AM

Post# of 252302
ELN: Interesting analysis by Motley Fool:

http://www.fool.com/news/commentary/2005/commentary05081014.htm

The article discounts the likely financial results from Tysabri, but touts ELN's NanoCrystal prospects. I'd be interested in what posters think of the following:

The entire pharmaceutical industry has two big problems. The first is that it is straining under the development cost of new drugs. The second is that the patents on nearly 60% of its blockbuster drugs are set to expire in the next few years. Elan's NanoCrystal can help address both issues and it is why, as I gaze into my NanoCrystal ball, I believe Elan continues to represent a solid long-term investment opportunity.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up